You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

canagliflozin

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial run by the NIDDK (Placebo, Canagliflozin)

Completed
  • Healthy Volunteers
  • Placebo
  • Canagliflozin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Mulberry Twig Alkaloid Tablet
  • Canagliflozin
  • Nanjing, China
    Jianhua Ma
May 3, 2023

Chronic Heart Failure, Acute Decompensated Heart Failure, Diabetes Trial in Giza (Canagliflozin)

Recruiting
  • Chronic Heart Failure
  • +2 more
  • Giza, Egypt
    National heart institute
Oct 11, 2022

Diabetes, Type 2 Trial in Decatur (canagliflozin, )

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • canagliflozin
  • placebo
  • Decatur, Georgia
    Atlanta VA Medical Center
Aug 12, 2022

Diabetes Type 2, Coronary Artery Disease Trial (Canagliflozin, Placebo)

Not yet recruiting
  • Diabetes Type 2
  • Coronary Artery Disease
  • Canagliflozin
  • Placebo
  • (no location specified)
Jun 16, 2022

Type 2 Diabetes With Complication Trial in Xi'an (Canagliflozin, Pioglitazone)

Recruiting
  • Type 2 Diabetes Mellitus With Complication
  • Xi'an, Shannxi, China
    First Affiliated Hospital Xi'an Jiaotong University
Aug 22, 2022

Type 2 Diabetes With Complication Trial (Canagliflozin, Pioglitazone)

Not yet recruiting
  • Type 2 Diabetes Mellitus With Complication
  • (no location specified)
Jul 5, 2022

PreDiabetes, Hiv Trial in Shanghai (Canagliflozin, Placebo)

Recruiting
  • PreDiabetes
  • Hiv
  • Canagliflozin
  • Placebo
  • Shanghai, Shanghai, China
    Intervention Effect of Canagliflozin on Prediabetes in Patients
Feb 19, 2022

Diabetes, Type 2 Trial (Canagliflozin)

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Canagliflozin
  • (no location specified)
Dec 7, 2021

Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)

Completed
Has Results
  • Type 1 Diabetes
  • canagliflozin
  • basal interruption without canagliflozin
  • New Haven, Connecticut
    Yale University School of Medicine
Sep 17, 2021

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Canagliflozin
  • +4 more
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Type 2 Diabetes, Diabetic Kidney Disease Trial in Aurora, Boston, Ann Arbor (canagliflozin, Aminohippurate Sodium Inj 20%)

Recruiting
  • Type 2 Diabetes
  • Diabetic Kidney Disease
  • canagliflozin
  • Aminohippurate Sodium Inj 20%
  • Aurora, Colorado
  • +3 more
Aug 17, 2022

Diabetic Nephropathy Trial in Japan (Canagliflozin, Placebo)

Completed
  • Diabetic Nephropathy
  • Canagliflozin
  • Placebo
  • Aichi, Japan
  • +25 more
Sep 2, 2021

Diabetes, Type 2, Obesity Trial in Cleveland (canagliflozin, Placebo (for canagliflozin))

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Obesity
  • canagliflozin
  • Placebo (for canagliflozin)
  • Cleveland, Ohio
    Cleveland Clinic
Oct 23, 2020

Diabetes, Type 2 Trial (Canagliflozin, Dapagliflozin, Empagliflozin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Canagliflozin
  • +2 more
  • (no location specified)
Mar 10, 2021

Type 2 Diabetes Trial in San Antonio (Canagliflozin, Liraglutide)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • San Antonio, Texas
    University of Texas Health Science Center at San Antonio
Dec 10, 2019

Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)

Completed
  • Diabetes Mellitus, Type 2
  • Canagliflozin
  • +4 more
  • Leicester, Leicestershire, United Kingdom
  • +1 more
Jan 29, 2020

Replication of the CANVAS Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Canagliflozin
  • DPP-4 inhibitor
  • Boston, Massachusetts
    Brigham & Women's Hospital
Dec 30, 2019

Heart Failure, Systolic, Diabetes, Type 2 Trial in Richmond (Canagliflozin, Sitagliptin)

Completed
Has Results
  • Heart Failure, Systolic
  • Diabetes Mellitus, Type 2
  • Richmond, Virginia
    Virginia Commonwealth University
Oct 28, 2019

Type 2 Diabetes Trial in Beijing (Dapagliflozin, Empagliflozin, Canagliflozin)

Unknown status
  • Type 2 Diabetes Mellitus
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +118 more
Jan 8, 2020

Type 2 Diabetes Trial in Kanto, Kinki, Tohoku (Teneligliptin, Canagliflozin, Placebo)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Kanto, Japan
  • +2 more
Oct 3, 2018

Type 2 Diabetes Trial in Kanto, Kinki, Tohoku (Canagliflozin, Teneligliptin, Placebo)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Canagliflozin
  • +2 more
  • Kanto, Japan
  • +2 more
Oct 3, 2018

s on Risk of Heart Failure Hospitalization and Amputation for

Completed
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Canagliflozin
  • +8 more
  • Titusville, New Jersey
    Janssen Investigative Site
Aug 24, 2018